ClinVar Miner

Submissions for variant NM_000244.3(MEN1):c.1633C>T (p.Pro545Ser) (rs745404679)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000231689 SCV000291288 uncertain significance Multiple endocrine neoplasia, type 1 2018-12-21 criteria provided, single submitter clinical testing This sequence change replaces proline with serine at codon 540 of the MEN1 protein (p.Pro540Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. This variant is present in population databases (rs745404679, ExAC 0.05%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in an individual affected with multiple endocrine neoplasia type 1 (MEN1) (PMID: 12652570), an individual affected with sporadic pituitary macroadenoma (PMID: 23321498), and individuals in the Universal Mutation Database (PMID: 10612827). ClinVar contains an entry for this variant (Variation ID: 200987). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000679251 SCV000338793 uncertain significance not provided 2016-01-08 criteria provided, single submitter clinical testing
Ambry Genetics RCV000575915 SCV000664573 uncertain significance Hereditary cancer-predisposing syndrome 2019-01-22 criteria provided, single submitter clinical testing Insufficient or conflicting evidence;Other data supporting benign classification;Co-occurence with a mutation in another gene that clearly explains a proband's phenotype
PreventionGenetics,PreventionGenetics RCV000679251 SCV000805922 uncertain significance not provided 2017-10-27 criteria provided, single submitter clinical testing
Mendelics RCV000231689 SCV000838449 uncertain significance Multiple endocrine neoplasia, type 1 2018-07-02 criteria provided, single submitter clinical testing
CHLA Center for Personalized Medicine,Children's Hospital, Los Angeles RCV000735331 SCV000854485 uncertain significance Leukodystrophy; Dystonia; Developmental regression; Abnormality of the cerebral white matter criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.